Rep. Val T. Hoyle Sells CME Group Inc. (NASDAQ:CME) Shares

Key Points

• Representative Val T. Hoyle sold between $1,001 and $15,000 in shares of CME Group Inc. (NASDAQ:CME) on September 23rd, 2025, in her "FIDELITY ROLLOVER IRA" account.
• CME Group has recently posted a 10.4% year-over-year increase in revenue, reporting $1.69 billion for the quarter along with EPS of $2.96, beating analysts' expectations.
• The company announced a quarterly dividend of $1.25 per share, resulting in an annualized dividend of $5.00 with a dividend yield of 1.8%.

Representative Val T. Hoyle (D-Oregon) recently sold shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on September 23rd. The trade occurred in the Representative's "FIDELITY ROLLOVER IRA" account.

Representative Val T. Hoyle also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Marriott International NASDAQ: MAR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Transdigm Group NYSE: TDG on 9/23/2025.
• Sold $1,001 - $15,000 in shares of H&R Block NYSE: HRB on 9/23/2025.
• Sold $1,001 - $15,000 in shares of NIKE NYSE: NKE on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Bank of New York Mellon NYSE: BK on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Cisco Systems NASDAQ: CSCO on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Pentair NYSE: PNR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Heico NYSE: HEI.A on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Target NYSE: TGT on 9/23/2025.

CME Group Stock Up 1.0%

NASDAQ CME opened at $271.45 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The stock has a fifty day moving average of $268.89 and a 200-day moving average of $271.17. The stock has a market capitalization of $97.83 billion, a P/E ratio of 26.28, a price-to-earnings-growth ratio of 5.67 and a beta of 0.41.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the previous year, the firm earned $2.56 earnings per share. The company's revenue was up 10.4% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Insider Transactions at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the firm's stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares of the company's stock, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 over the last quarter. 0.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On CME Group

A number of large investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its holdings in shares of CME Group by 11.4% in the 1st quarter. Farther Finance Advisors LLC now owns 5,506 shares of the financial services provider's stock valued at $1,444,000 after purchasing an additional 563 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in shares of CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after purchasing an additional 47 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of CME Group by 24.5% in the 1st quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider's stock valued at $1,859,000 after purchasing an additional 1,381 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of CME Group by 649.6% in the 1st quarter. Assenagon Asset Management S.A. now owns 113,836 shares of the financial services provider's stock valued at $30,200,000 after acquiring an additional 98,650 shares during the last quarter. Finally, CX Institutional lifted its stake in shares of CME Group by 10.1% in the 1st quarter. CX Institutional now owns 2,876 shares of the financial services provider's stock valued at $763,000 after acquiring an additional 265 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Barclays dropped their price objective on CME Group from $298.00 to $280.00 and set an "equal weight" rating on the stock in a research note on Wednesday. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. JPMorgan Chase & Co. upped their price objective on CME Group from $246.00 to $252.00 and gave the company an "underweight" rating in a research note on Thursday, September 25th. TD Cowen upped their price objective on CME Group from $281.00 to $288.00 and gave the company a "hold" rating in a research note on Wednesday. Finally, Morgan Stanley upped their price objective on CME Group from $303.00 to $312.00 and gave the company an "overweight" rating in a research note on Wednesday, October 1st. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $281.00.

About Representative Hoyle

Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon's 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon's 4th Congressional District. She declared candidacy for the 2026 election. Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.